These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 26253646
1. Incidence and risk factors for central venous access port-related infection in Chinese cancer patients. Wang TY, Lee KD, Chen PT, Chen MC, Chen YY, Huang CE, Kuan FC, Chen CC, Lu CH. J Formos Med Assoc; 2015 Nov; 114(11):1055-60. PubMed ID: 26253646 [Abstract] [Full Text] [Related]
5. Clinical outcomes of totally implantable venous access port placement via the axillary vein in patients with head and neck malignancy. Hong S, Seo TS, Song MG, Seol HY, Suh SI, Ryoo IS. J Vasc Access; 2019 Mar; 20(2):134-139. PubMed ID: 29923460 [Abstract] [Full Text] [Related]
6. Infection of totally implantable venous access devices: A review of the literature. Pinelli F, Cecero E, Degl'Innocenti D, Selmi V, Giua R, Villa G, Chelazzi C, Romagnoli S, Pittiruti M. J Vasc Access; 2018 May; 19(3):230-242. PubMed ID: 29512430 [Abstract] [Full Text] [Related]
8. Effect of catheter diameter on left innominate vein in breast cancer patients after totally implantable venous access port placement. Song MG, Seo TS, Kim YH, Cho SB, Chung HH, Lee SH, Jung E. J Vasc Access; 2018 Nov; 19(6):615-619. PubMed ID: 29560786 [Abstract] [Full Text] [Related]
9. Polyurethane versus silicone catheters for central venous port devices implanted at the forearm. Wildgruber M, Lueg C, Borgmeyer S, Karimov I, Braun U, Kiechle M, Meier R, Koehler M, Ettl J, Berger H. Eur J Cancer; 2016 May; 59():113-124. PubMed ID: 27023050 [Abstract] [Full Text] [Related]
11. Higher complication risk of totally implantable venous access port systems in patients with advanced cancer - a single institution retrospective analysis. Chang YF, Lo AC, Tsai CH, Lee PY, Sun S, Chang TH, Chen CC, Chang YS, Chen JR. Palliat Med; 2013 Feb; 27(2):185-91. PubMed ID: 22126844 [Abstract] [Full Text] [Related]
16. Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis. Berardi R, Rinaldi S, Santini D, Vincenzi B, Giampieri R, Maccaroni E, Marcucci F, Francoletti M, Onofri A, Lucarelli A, Pierantoni C, Tonini G, Cascinu S. Support Care Cancer; 2015 May; 23(5):1295-302. PubMed ID: 25326782 [Abstract] [Full Text] [Related]
17. Complication-related removal of totally implantable venous access port systems: Does the interval between placement and first use and the neutropenia-inducing potential of chemotherapy regimens influence their incidence? A four-year prospective study of 4045 patients. Kakkos A, Bresson L, Hudry D, Cousin S, Lervat C, Bogart E, Meurant JP, El Bedoui S, Decanter G, Hannebicque K, Regis C, Hamdani A, Penel N, Tresch-Bruneel E, Narducci F. Eur J Surg Oncol; 2017 Apr; 43(4):689-695. PubMed ID: 27889197 [Abstract] [Full Text] [Related]
19. Sustained low incidence of central venous catheter-related infections over six years in a Swedish hospital with an active central venous catheter team. Hammarskjöld F, Berg S, Hanberger H, Taxbro K, Malmvall BE. Am J Infect Control; 2014 Feb; 42(2):122-8. PubMed ID: 24485369 [Abstract] [Full Text] [Related]
20. Incidence and risk factors of infectious complications related to implantable venous-access ports. Shim J, Seo TS, Song MG, Cha IH, Kim JS, Choi CW, Seo JH, Oh SC. Korean J Radiol; 2014 Feb; 15(4):494-500. PubMed ID: 25053910 [Abstract] [Full Text] [Related] Page: [Next] [New Search]